Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole vs Nissen Fundoplication in GERD
NCT00994708Phase 3Completed
- Sponsor
- Tampere University Hospital
- Start
- Dec 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of esomeprazole in gastroesophageal reflux disease (GERD) (2 arms), sponsored by Tampere University Hospital. Primary endpoint: Bronchial Responsiveness. Started Dec 2004; status: completed.
02
Drugs
esomeprazole
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT00994708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00994708.